WallStreetZenWallStreetZen

NASDAQ: ADMP
Adamis Pharmaceuticals Corp Stock Ownership - Who owns Adamis Pharmaceuticals?

Insider buying vs selling

Have Adamis Pharmaceuticals Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADMP insiders and whales buy or sell their stock.

ADMP Shareholders

What type of owners hold Adamis Pharmaceuticals Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ahmed Shayan Fazlur Rahman18.17%31,614,954$65.44MInsider
Armistice Capital LLC8.33%14,500,000$30.02MInstitution
John M. Gregory4.05%7,053,993$14.60MInsider
Vanguard Group Inc3.73%6,483,945$13.42MInstitution
Richard L. Aloi2.07%3,593,039$7.44MInsider
Blackrock Inc1.59%2,766,939$5.73MInstitution
Dennis J. Phd Carlo1.14%1,976,061$4.09MInsider
Thomas J. Tisch1.03%1,796,585$3.72MInsider
Geode Capital Management LLC0.76%1,326,654$2.75MInstitution
Eddie Wabern Glover0.43%741,668$1.54MInsider

1 of 3

ADMP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADMP15.85%28.23%
ASRT42.23%34.82%Net SellingNet Selling
SNDL7.24%0.00%
PETQ83.17%16.83%Net SellingNet Selling
CGC10.08%55.89%Net Buying

Adamis Pharmaceuticals Stock Ownership FAQ

Who owns Adamis Pharmaceuticals?

Adamis Pharmaceuticals (NASDAQ: ADMP) is owned by 15.85% institutional shareholders, 28.23% Adamis Pharmaceuticals insiders, and 55.91% retail investors. Ahmed Shayan Fazlur Rahman is the largest individual Adamis Pharmaceuticals shareholder, owning 31.61M shares representing 18.17% of the company. Ahmed Shayan Fazlur Rahman's Adamis Pharmaceuticals shares are currently valued at $65.44M.

If you're new to stock investing, here's how to buy Adamis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.